These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7977509)

  • 41. Ocular manifestation of hairy cell leukemia with dramatic response to 2-chloro-deoxy-adenosine.
    Robinson A; Eting E; Zeidman A; Djaldetti M; Mittelman M; Savir H
    Am J Ophthalmol; 1996 Jan; 121(1):97-9. PubMed ID: 8554090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bone marrow fibrosis during therapy of hairy cell leukemia].
    Dĕdic K; Zák P
    Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia.
    Chacko J; Murphy C; Duggan C; O'Briain DS; Browne PV; McCann SR
    Br J Haematol; 1999 Jun; 105(4):1145-6. PubMed ID: 10554836
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature.
    Hassan R; Gupta M; Kern W; Ozer H
    Leuk Lymphoma; 2004 Oct; 45(10):2149-52. PubMed ID: 15370263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy.
    Hacioglu S; Bilen Y; Eser A; Sivgin S; Gurkan E; Yildirim R; Aydogdu I; Dogu MH; Yilmaz M; Kayikci O; Tombak A; Kuku I; Celebi H; Akay MO; Esen R; Korkmaz S; Keskin A
    Hematol Oncol; 2015 Dec; 33(4):192-8. PubMed ID: 25393847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
    Greyz N; Saven A
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Halogenoderma of the forearm caused by 2-chlorodeoxyadenosine treatment.
    Zevin S; Hershko C; Rosenmann E
    Am J Hematol; 1996 Nov; 53(3):209-10. PubMed ID: 8895703
    [No Abstract]   [Full Text] [Related]  

  • 51. Histological examination of the retinal ganglion layer in rabbits after experimental administration of the new immunosuppressive medicine--Cladribine.
    Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):376-80. PubMed ID: 12898865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrastructural changes of retinal ganglion cells in rabbits of New Zealand breed after experimental administration of 2-CDA (Cladribine).
    Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):381-6. PubMed ID: 12898866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P; Shpilberg O; Ben-Bassat I
    Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
    [No Abstract]   [Full Text] [Related]  

  • 54. Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia.
    Sarmiento MA; Neme D; Fornari MC; Bengió RM
    Leuk Lymphoma; 2000 Nov; 39(5-6):657-9. PubMed ID: 11342351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
    Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
    Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemia.
    Bhargava R; Barbashina V; Filippa DA; Teruya-Feldstein J
    Leuk Lymphoma; 2004 May; 45(5):1043-8. PubMed ID: 15291365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine.
    Tombak A; Aygün S; Serinsöz E; Tiftik EN
    Korean J Intern Med; 2015 Sep; 30(5):739-41. PubMed ID: 26354071
    [No Abstract]   [Full Text] [Related]  

  • 58. Phase II clinical study of cladribine in the treatment of hairy cell leukemia.
    Machii T; Chou T; Suzuki M; Ohe Y; Katagiri S; Kitano EK; Kitano K; Fujiyama Y; Izumi T; Shimazaki C; Nanba K; Ohashi Y; Kitani T;
    Int J Hematol; 2005 Oct; 82(3):230-5. PubMed ID: 16207596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
    Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
    Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
    Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.